Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Nanus

Showing results (21-30 of 168) with videos related to

Pageof 17
Sort By:
Journal of Medical Case Reports|November 18, 2009
Carcinomatous meningitis in a patient with Her2/neu expressing bladder cancer following trastuzumab and chemotherapy: a case report and review of the literatureOscar B Goodman, Matthew I Milowsky, Jodi Kaplan, et al.
Cancer|January 30, 2002
Active chemotherapy for collecting duct carcinoma of the kidney: a case report and review of the literatureMatthew I Milowsky, Alyssa Rosmarin, Satish K Tickoo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2004
Chemosensitization of androgen-independent prostate cancer with neutral endopeptidaseMakoto Sumitomo, Tomohiko Asano, Junichi Asakuma, et al.
American Journal of Clinical and Experimental Urology|November 19, 2021
A case report of a patient with plasmacytoid urothelial cancer with significant response to HER2-targeting therapy and enfortumab vedotinMichael Sun, Ariel Schaap, Brian D Robinson, et al.
Physical Biology|February 15, 2019
Androgen receptor nuclear localization correlates with AR-V7 mRNA expression in circulating tumor cells (CTCs) from metastatic castration resistance prostate cancer patientsDaniel Worroll, Giuseppe Galletti, Ada Gjyrezi, et al.
Protein Science : a Publication of the Protein Society|April 24, 2009
Rational redesign of neutral endopeptidase binding to merlin and moesin proteinsMasha Y Niv, Katsuyuki Iida, Rong Zheng, et al.
Journal of the American Board of Family Medicine : JABFM|July 27, 2022
Nearly All Cancer Survivors Return to Primary CareLaura C Pinheiro, Mangala Rajan, Monika M Safford, et al.
Urologic Oncology|May 11, 2010
Carboplatin plus paclitaxel therapy after docetaxel in men with metastatic castrate resistant prostate cancerStephanie Jeske, Scott T Tagawa, Olugbenga Olowokure, et al.
The Journal of Urology|March 23, 2011
Transitional cell carcinoma of the bladder: racial and gender disparities in survival (1993 to 2002), stage and grade (1993 to 2007)Katherine Mallin, Kevin A David, Peter R Carroll, et al.
Cancer Biology & Therapy|March 5, 2010
Phase I trial of ATRA-IV and Depakote in patients with advanced solid tumor malignanciesKevin A David, Nigel P Mongan, Christopher Smith, et al.
Pageof 17

Showing results (21-30 of 168) with videos related to

Sort By:
Pageof 17
Journal of Medical Case Reports|November 18, 2009
Carcinomatous meningitis in a patient with Her2/neu expressing bladder cancer following trastuzumab and chemotherapy: a case report and review of the literatureOscar B Goodman, Matthew I Milowsky, Jodi Kaplan, et al.
Cancer|January 30, 2002
Active chemotherapy for collecting duct carcinoma of the kidney: a case report and review of the literatureMatthew I Milowsky, Alyssa Rosmarin, Satish K Tickoo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2004
Chemosensitization of androgen-independent prostate cancer with neutral endopeptidaseMakoto Sumitomo, Tomohiko Asano, Junichi Asakuma, et al.
American Journal of Clinical and Experimental Urology|November 19, 2021
A case report of a patient with plasmacytoid urothelial cancer with significant response to HER2-targeting therapy and enfortumab vedotinMichael Sun, Ariel Schaap, Brian D Robinson, et al.
Physical Biology|February 15, 2019
Androgen receptor nuclear localization correlates with AR-V7 mRNA expression in circulating tumor cells (CTCs) from metastatic castration resistance prostate cancer patientsDaniel Worroll, Giuseppe Galletti, Ada Gjyrezi, et al.
Protein Science : a Publication of the Protein Society|April 24, 2009
Rational redesign of neutral endopeptidase binding to merlin and moesin proteinsMasha Y Niv, Katsuyuki Iida, Rong Zheng, et al.
Journal of the American Board of Family Medicine : JABFM|July 27, 2022
Nearly All Cancer Survivors Return to Primary CareLaura C Pinheiro, Mangala Rajan, Monika M Safford, et al.
Urologic Oncology|May 11, 2010
Carboplatin plus paclitaxel therapy after docetaxel in men with metastatic castrate resistant prostate cancerStephanie Jeske, Scott T Tagawa, Olugbenga Olowokure, et al.
The Journal of Urology|March 23, 2011
Transitional cell carcinoma of the bladder: racial and gender disparities in survival (1993 to 2002), stage and grade (1993 to 2007)Katherine Mallin, Kevin A David, Peter R Carroll, et al.
Cancer Biology & Therapy|March 5, 2010
Phase I trial of ATRA-IV and Depakote in patients with advanced solid tumor malignanciesKevin A David, Nigel P Mongan, Christopher Smith, et al.
Pageof 17